Please provide your email address to receive an email when new articles are posted on . One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results ...

April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...

Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that ...

Field trials in real-world environments show Multi-Link Operation (MLO) with commercial devices improving uplink ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...

GEMINI-Perioperative (PeriOp) Gastric: A phase 2 study of novel agent-based combinations as PeriOp therapy for previously untreated, locally advanced resectable gastric, gastroesophageal junction (GEJ ...

The planned Phase 2 trial will evaluate the efficacy, safety and tolerability of Lucid-MS in people with MS. Quantum ...

The ALSTARS Trial is a well powered randomized, multi-center, double-blind, placebo-controlled, 24-week study of COYA 302 in people with Amyotrophic Lateral Sclerosis (ALS) Patients completing the ...

A phase 1, open-label, dose expansion cohort of the tolerability of tolododekin alfa (ANK-101) in combination with cemiplimab in cutaneous squamous cell carcinoma. Phase I dose escalation and ...

Affinia Therapeutics has received approval from Health Canada for its clinical trial application (CTA) to begin the UPBEAT ...

Sanofi’s (SNY) lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP, the company said on Tuesday. Lunsekimig, a novel bispecific Nanobody VHH, is made ...

OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant's dosing following the ...